SJZ No.4 Pharmaceutical SJZ No.4 Pharmaceutical
  • HOME

  • ABOUT US

      ABOUT US
      SSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
      • Company Profile

      • Development History

      • Company Culture

      • Video Center

      ABOUT US
      产品服务专区
      下载中心 留言咨询 联系我们
      业务咨询电话:
      /
  • INNOVATION

      INNOVATION
      SSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
      • Innovation and R&D

      • Information

      INNOVATION
      产品服务专区
      下载中心 留言咨询 联系我们
      业务咨询电话:
      /
  • PRODUCTS

      PRODUCTS
      • Tonify and calm the spirit

      • Respiratory system

      • Systemic anti-infective drugs

      • Digestive Tract and Metabolism

      • Cardiovascular system

      • Blood and Hematopoietic Organs

      • Medical solution

      • Central Nervous System

      • Active Pharmaceutical Ingredient

      • Medical packaging materials

      • Makeup remover

      PRODUCTS
      产品服务专区
      下载中心 留言咨询 联系我们
      业务咨询电话:
      /
  • RECRUIT

      RECRUIT
      It has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
      • Talent Concept

      • Career Development

      • Campus Recruitment

      • Social Recruitment

      RECRUIT
      产品服务专区
      下载中心 留言咨询 联系我们
      业务咨询电话:
      /
  • SUBSIDIARIES

      SUBSIDIARIES
      The company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
      • Guangxiang Technology

      • Guangxiang Pharmaceutical

      • Guolong Pharmaceutical

      • Jiangsu Best

      • Hanlin Biotechnology

      SUBSIDIARIES
      产品服务专区
      下载中心 留言咨询 联系我们
      业务咨询电话:
      /
  • CONTACT

      CONTACT
      We will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
      • Contact us

      • Sales Network

      CONTACT
      产品服务专区
      下载中心 留言咨询 联系我们
      业务咨询电话:
      /

Corporate Email

中文/EN

简体中文

English

News Center

News Center

  • 位置:

Honors Announcement

Group News

Media Reports

Wireless Shijiazhuang | New Momentum for Shisiyao’s Ascent to Greater Heights


Category:

Media Reports

发布时间:2024-01-18

【概要描述】 New Momentum for Shisi Pharmaceutical’s Ascent to Greater Heights
Wireless Shijiazhuang | New Momentum for Shisiyao’s Ascent to Greater Heights
Wireless Shijiazhuang | New Momentum for Shisiyao’s Ascent to Greater Heights

Keywords:


Previous Page

Exclusive Interview with Shijiazhuang Daily: Promoting Talent Exchange and Achieving Breakthroughs in Key Technologies—An Interview with Sun Lijie, Executive President of Shijiazhuang Sihua Pharmaceutical Group and Director of the Pharmaceutical Research Institute

Hebei Daily | Information Technology Powers Production of 2 Million Bottles (Bags) of Large-Volume Infusions—A Glimpse Inside Workshop 312 of Shisiyao Group

Next page

Previous page:

Exclusive Interview with Shijiazhuang Daily: Promoting Talent Exchange and Achieving Breakthroughs in Key Technologies—An Interview with Sun Lijie, Executive President of Shijiazhuang Sihua Pharmaceutical Group and Director of the Pharmaceutical Research Institute

Next page:

Hebei Daily | Information Technology Powers Production of 2 Million Bottles (Bags) of Large-Volume Infusions—A Glimpse Inside Workshop 312 of Shisiyao Group

Recommended News


Good News! On the same day, two products—Metoclopramide Hydrochloride Injection (2 mL: 10 mg) and Compound Electrolyte Sodium Acetate Glucose Injection (250 mL and 500 mL)—from Shijiazhuang Sihua Pharmaceutical Group were approved.

2026-04-10

Shijiazhuang Institute of Science and Technology Conducts Enterprise Visit and Job-Expansion Activities at Shijiazhuang Sihua Pharmaceutical Group

2026-04-03

Shijiazhuang Sihua Pharmaceutical Group’s Tranexamic Acid Tablets (0.25 g) Have Been Approved

2026-04-03

Shijiazhuang Sihua Pharmaceutical Group’s Guolong Pharmaceutical Receives Approval for Upadacitinib API

2026-03-30

Share to

Facebook Linkedin Twitter Tumblr Pinterest
SJZ No.4 Pharmaceutical

SERVICE HOTLINE

400-616-8689

Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone

Tel.: +86-311-67167130

Email: office@sjzsiyao.com

Mobile site

Mobile site

Wechat

Wechat

E code

E code

  • HOME

  • ABOUT US

    • Company Profile

    • Development History

    • Company Culture

    • Video Center

  • INNOVATION

    • Innovation and R&D

    • Information

  • PRODUCTS

    • Tonify and calm the spirit

    • Respiratory system

    • Systemic anti-infective drugs

    • Digestive Tract and Metabolism

    • Cardiovascular system

    • Blood and Hematopoietic Organs

    • Medical solution

    • Central Nervous System

    • Active Pharmaceutical Ingredient

    • Medical packaging materials

    • Makeup remover

  • RECRUIT

    • Talent Concept

    • Career Development

    • Campus Recruitment

    • Social Recruitment

  • SUBSIDIARIES

    • Guangxiang Technology

    • Guangxiang Pharmaceutical

    • Guolong Pharmaceutical

    • Jiangsu Best

    • Hanlin Biotechnology

  • CONTACT

    • Contact us

    • Sales Network

SEO TAG

CONTACT

MARKET

Facebook Linkedin Twitter Tumblr Pinterest

Non-Commercial (Filing) – 2025-0091

Powered by 300.cn | TAG | Privacy Policy